Aquaretic Agents: What's Beyond the Treatment of Hyponatremia?

E-ISSN： 1873-4286|13|8|865-871

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.8, 2007-03, pp. : 865-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 249-258

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the treatment of hyponatremia

By Hussain Sabiha M Sureshkumar Kalathil K Marcus Richard J

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2729-2741

Informa Healthcare

Access to resources Recommend Favorite

Aquaretic and hormonal effects of a vasopressin V 2 receptor antagonist after acute and long-term treatment in rats

By Lacour C. Galindo G. Canals F. Segondy D. Cazaubon C. Serradeil-Le Gal C. Roccon A. Nisato D.

European Journal of Pharmacology, Vol. 394, Iss. 1, 2000-04 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 4, 2014-01 ,pp. : 362-372

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-sensitising agents: beyond thiazolidinediones

By Petrie John R Perry Colin G

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 1, 2002-05 ,pp. : 165-174

Informa Healthcare

Access to resources Recommend Favorite